Rebecca Porter, MD, PhD, on gynecologic cancer treatment | Dana-Farber Cancer Institute

FRa expression and sequencing ADCs in endometrial cancerПодробнее

AACR24: Rebecca Porter, MD, Endometrial Cancer | Dana-Farber Cancer InstituteПодробнее

Clonal hematopoiesis mutations in ovarian carcinomasПодробнее

Antibody-drug conjugates in gynecological cancersПодробнее

Mirvetuximab soravtansine with pembrolizumab in MSS endometrial cancerПодробнее

GYN Oncology Virtual Symposium Series | Roundtable Discussion - September 2022Подробнее